Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Efalizumab")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 167

  • Page / 7
Export

Selection :

  • and

T-cell clone associated with efalizumab therapyLYNCH, M; MURPHY, K; SLABY, J et al.Clinical and experimental dermatology (Print). 2011, Vol 36, Num 1, pp 99-100, issn 0307-6938, 2 p.Article

A case of natural killer cell monoclonal expansion during efalizumab treatment in a patient with psoriasisCAPRONI, M; VOLPI, W; CHIARINI, C et al.British journal of dermatology (1951). 2009, Vol 160, Num 4, pp 896-897, issn 0007-0963, 2 p.Article

Efalizumab-induced hypertrichosisRALLIS, E; TAPINIS, P; VERROS, C. D et al.British journal of dermatology (1951). 2008, Vol 158, Num 5, pp 1158-1159, issn 0007-0963, 2 p.Article

Delayed generalized inflammatory psoriasis flare during efalizumab treatmentMARTIN, B; SANCHEZ-CARAZO, J. L; PEREZ-FERRIOLS, A et al.British journal of dermatology (1951). 2009, Vol 161, Num 1, pp 212-213, issn 0007-0963, 2 p.Article

Exacerbation of Psoriasis under Efalizumab TherapyRALLIS, Efstathios; VERROS, Constantinos; KARANIKOLA, Evmorfia et al.Journal of cutaneous medicine and surgery. 2009, Vol 13, Num 2, pp 106-109, issn 1203-4754, 4 p.Article

Efalizumab-associated thrombocytopeniaGRIM HOSTELLER, Sarah; ZIRWAS, Matthew; BECHTEL, Mark A et al.Journal of the American Academy of Dermatology. 2007, Vol 57, Num 4, pp 707-710, issn 0190-9622, 4 p.Article

Serum Sickness-Like Reaction Associated with EfalizumabASHRAF-BENSON, Sadia; WALL, Geoffrey C; VEACH, Lisa A et al.The Annals of pharmacotherapy. 2009, Vol 43, Num 2, pp 383-386, issn 1060-0280, 4 p.Article

Guillain-Barré syndrome after short-course efalizumab treatmentTURATTI, Marco; TAMBURIN, Stefano; IDONE, Domenico et al.Journal of neurology. 2010, Vol 257, Num 8, pp 1404-1405, issn 0340-5354, 2 p.Article

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasisPAPP, Kim A; HO, Vincent; LANGIEY, Richard et al.Journal of cutaneous medicine and surgery. 2005, Vol 9, pp 26-32, issn 1203-4754, 7 p., SUP1Article

Efalizumab in the treatment of psoriasis : mode of action, clinical indications, efficacy, and safetySCHÖN, Michael P.Clinics in dermatology. 2008, Vol 26, Num 5, pp 509-514, issn 0738-081X, 6 p.Article

Efalizumab, a reversible T-cell modulator for psoriasisSHEAR, Neil H; LANGLEY, Richard G; HO, Vincent et al.Journal of cutaneous medicine and surgery. 2005, Vol 9, pp 4-9, issn 1203-4754, 6 p., SUP1Article

Efalizumab-associated papular psoriasis : An adverse reaction to efalizumab in three casesANTONUCCI, Angela; BARDAZZI, Federico; BALESTRI, Riccardo et al.Journal of dermatological treatment. 2009, Vol 20, Num 1, pp 61-62, issn 0954-6634, 2 p.Article

Eczematous Dermatosis and Thrombocytosis Induced by Efalizumab : Two New Side EffectsFIRMIN, D; ROGUEDAS, A. M; LEMASSON, G et al.Dermatology (Basel). 2008, Vol 217, Num 3, pp 203-206, issn 1018-8665, 4 p.Article

Efalizumab : Dauertherapie der Psoriasis : Biologics bei Psoriasis = Efalizumab. Long-term treatment of psoriasis : Biologics for psoriasisPRINZ, J. C.Hautarzt. 2005, Vol 56, Num 9, pp 812-818, issn 0017-8470, 6 p.Article

Efalizumab-induced bullous pemphigoidANB DUONG, Tu; BUFFARD, Valérie; ANDRE, Chantal et al.Journal of the American Academy of Dermatology. 2010, Vol 62, Num 1, pp 161-162, issn 0190-9622, 2 p.Article

Response of Keratosis Lichenoides Chronica to Efalizumab TherapyMUNOZ-SANTOS, Carlos; YEBENES, Mireia; ROMANI, Jorge et al.Archives of dermatology (1960). 2009, Vol 145, Num 8, pp 867-869, issn 0003-987X, 3 p.Article

Urticaria Associated with Hyper-IgE in a Patient with Psoriasis Undergoing Treatment with EfalizumabSARACENO, Rosita; SCOTTO, Gea; CHIRICOZZI, Andrea et al.Acta dermato-venereologica. 2009, Vol 89, Num 4, pp 412-413, issn 0001-5555, 2 p.Article

Repigmentation of vitiligo during efalizumabWAKKEE, Marlies; ASSEN, Yvette J; BING THIO, H et al.Journal of the American Academy of Dermatology. 2008, Vol 59, Num 2, issn 0190-9622, S57-S58, SUPArticle

Treatment of Nail Psoriasis With Efalizumab : A Preliminary StudyLAMERSON, Cindy; STEVENS, Gayle; SAX, Kenji et al.Cutis (New York, NY). 2008, Vol 82, Num 3, pp 217-220, issn 0011-4162, 4 p.Article

Case reports : Efalizumab-associated lymphoproliferative diseaseBOMMAKANTI, Satya; PATIL, Amol; ESHOA, Camellia et al.Journal of drugs in dermatology. 2007, Vol 6, Num 6, pp 646-648, issn 1545-9616, 3 p.Article

Treatment of alopecia areata partim universalis with efalizumabKAELIN, Ursula; SAID HASSAN, Akmhal; BRAATHEN, Lasser Roger et al.Journal of the American Academy of Dermatology. 2006, Vol 55, Num 3, pp 529-532, issn 0190-9622, 4 p.Article

Practical guidelines for the long-term treatment of psoriasis with efalizumabLEONARDI, Craig L.Journal of the American Academy of Dermatology. 2006, Vol 54, Num 4, issn 0190-9622, 40 p., SUPSerial Issue

A favourable benefit/risk ratio with efalizumab : A review of the clinical evidencePOULIN, Yves; PAPP, Kim A; CAREY, Wayne et al.Journal of cutaneous medicine and surgery. 2005, Vol 9, pp 10-17, issn 1203-4754, 8 p., SUP1Article

Fatal PML associated with efalizumab therapy: Insights into integrin αLβ2 in JC virus controlSCHWAB, N; ULZHEIMER, J. C; BRÜCK, W et al.Neurology. 2012, Vol 78, Num 7, pp 458-467, issn 0028-3878, 10 p.Article

Efalizumab treatment of psoriasis vulgaris: a cohort study in outpatient clinical practicePUIG, L; ROE, E; GARIA-NAVARRO, X et al.Clinical and experimental dermatology (Print). 2009, Vol 34, Num 4, pp 469-475, issn 0307-6938, 7 p.Article

  • Page / 7